Johnson & Johnson has announced that it has committed to ensuring more than $500 million is dedicated...
The U.S. Food and Drug Administration (FDA) has approved BAQSIMI™ (glucagon) nasal powder 3 mg for the treatment o...
Health Catalyst, a leading provider of data and analytics technology and services to healthcare organizations has announ...
PORT WASHINGTON, N.Y (US). – July 20, 2019 – Pall Corporation, a global leader in filtration, separati...
Philadelphia, PA (July 17, 2019) – Oncoceutics, Inc. issues this announcement on Glioblastoma Awareness Day to r...
CEL-SCI Corporation (NYSE American: CVM) announced that one of its key collaborators from Rush University Medi...
Platelet BioGenesis, the leader in stem cell-derived, on-demand human platelets (PLTs+) and platelet-based therapeu...
Synthetic Biologics, a late-stage clinical company developing therapeutics that preserve the microbiome to protect ...
Executive Women in Bio (EWIB), a committee comprised of senior leaders in the life sciences and biopharma operating with...
The 11th annual Dealmakers’ Intentions Study from Syneos Health Consulting, an industry-leading biopharmaceutical ...
The Discovery Labs, a platform company formed by MLP Ventures, announced at BIO 2019 (Booth 4134) it is redeveloping Gla...
CHICAGO & REDWOOD CITY, Calif. InterVenn BioSciences, a life sciences and technology company developing an AI-drive...
AUSTIN, TX – June 3, 2019 – The Texas Healthcare and Bioscience Institute (THBI) is headed to Philadelphia t...
